Epidemiology and Cancers

The epidemiology of cancer is the study of the aspects affecting cancer, as a way to infer probable trends and causes. The study of cancer epidemiology customs epidemiological methods to find the source of cancer and to recognize and develop improved treatments. This extent of study must contend with glitches of lead time bias and length time bias. Lead time bias is the concept that early diagnosis may artificially inflate the survival statistics of a cancer, without really improving the natural history of the disease. Length bias is the perception that slower growing, more indolent tumors are more likely to be analyzed by screening tests, but improvements in diagnosing more cases of indolent cancer may not interpret into better patient outcomes after the execution of screening programs. An associated concern is over diagnosis, the tendency of screening tests to detect diseases that may not actually impact the patient's longevity. This problem especially applies to prostate cancer and PSA screening.

    Related Conference of Epidemiology and Cancers

    March 27-28, 2024

    6th International Conference on Digital Health

    London, UK
    April 24-25, 2024

    35th European Heart and Heart Failure Congress

    Paris, France
    June 21-22, 2024

    52nd Global Nursing & Healthcare Conference

    Rome, Italy
    September 09-10, 2024

    3rd Global Summit on Physiology and Metabolism of Thyroid

    Paris, France
    September 18-19, 2024

    29th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    September 19-20, 2024

    20th Global Biomarkers and Clinical Research Summit

    Amsterdam, Netherlands
    September 24-25, 2024

    5th Global Summit on Public Health

    Paris, France

    Epidemiology and Cancers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in